What are the factors driving the AI in genomics market?

The rising R&D spending and growing demand for tailored medications are driving AI in the genomics market. Collaborations among key companies are further fostering the market's expansion. Other factors driving the demand for AI in the genomics industry are the rapid advancements in AI technology and its cost-effectiveness. With the rapid advancements in AI technology, new AI-powered software solutions are being developed that are specifically designed for the genomics industry. These solutions are more sophisticated and efficient, enabling researchers to analyze and manage genomic data more effectively than ever before. AI algorithms and software solutions can help to automate many of the manual tasks involved in genomic research, reducing the need for human labor and making the process more cost-effective.

How big is the AI in genomics market?

The global AI in genomics market size was estimated at USD 1.26 billion in 2025 and is expected to reach USD 1.76 billion in 2026.

What is AI in genomics market growth?

The global AI in genomics market is expected to grow at a compound annual growth rate of 40.30% from 2026 to 2033 to reach USD 18.82 billion by 2033.

Which region accounted for the largest AI in genomics market share?

In 2025, North America AI in genomics market accounted for the largest revenue share of 38.36%. The market is driven by the integration of AI-based diagnostics, strong digital infrastructure, and high investment in clinical research. For instance, major U.S. cancer centers are deploying deep learning models for tumor classification and biomarker quantification, improving diagnostic accuracy and enabling personalized treatment strategies. In addition, strong presence of pharmaceutical and biotechnology companies drives market growth further.

Who are the key players in AI in genomics market?

Some of the key market players operating in the AI in genomics market are Microsoft Corporation; NVIDIA Corporation; DEEP GENOMICS; Data4Cure, Inc.; Freenome Holdings, Inc.; Thermo Fisher Scientific; Illumina, Inc.; SOPHiA GENETICS; BenevolentAI; Fabric Genomics; among others.